Quarterly report pursuant to sections 13 or 15(d)

Restatement of Previously Issued Condensed Financial Statements (Details)

v2.4.0.6
Restatement of Previously Issued Condensed Financial Statements (Details) (USD $)
 3 Months Ended 9 Months Ended 12 Months Ended 32 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Sep. 30, 2012
Sep. 30, 2011
Dec. 31, 2010
Dec. 31, 2011
Sep. 30, 2012
Jan. 16, 2010
Liabilities:                
Warrant liability $ 2,152,000   $ 2,152,000     $ 4,483,334 $ 2,152,000  
Total liabilities 4,506,360   4,506,360     6,745,040 4,506,360  
Maximum ordinary shares subject to possible redemption 40,988,724   40,988,724     39,128,238 40,988,724  
Equity                
Ordinary shares 2,172   2,172     2,359 2,172  
Additional paid-in capital 3,292,978   3,292,978     5,153,277 3,292,978  
Retained earnings (Deficit) accumulated during the development stage (1,704,851)   (1,704,851)     155,635 (1,704,851)  
Total shareholders' equity 5,000,001   5,000,001   21,491 5,000,001 5,000,001 0
Total liabilities and shareholders' equity 50,495,085   50,495,085     50,873,279 50,495,085  
Income Statement                
Gain on change in fair value of warrant liability 2,421,000 179,333 2,331,334 179,333     2,510,666  
Net (loss) income 2,259,980 (14,874) 1,860,486 (107,559) (23,409) (132,226) 1,704,851  
Basic and diluted earnings (net loss) per share (in dollars per share) $ 0.36 $ 0.00 $ 0.30 $ (0.03)        
Operating activities:                
Net (loss) income 2,259,980 (14,874) 1,860,486 (107,559) (23,409) (132,226) 1,704,851  
Gain on change in fair value of warrant liability (2,421,000) (179,333) (2,331,334) (179,333)     (2,510,666)  
Scenario, Previously Reported [Member]
                
Liabilities:                
Warrant liability 0   0       0  
Total liabilities 2,354,360   2,354,360       2,354,360  
Maximum ordinary shares subject to possible redemption 43,140,724   43,140,724       43,140,724  
Equity                
Ordinary shares 1,956   1,956       1,956  
Additional paid-in capital 5,803,861   5,803,861       5,803,861  
Retained earnings (Deficit) accumulated during the development stage (805,816)   (805,816)       (805,816)  
Total shareholders' equity 5,000,001   5,000,001       5,000,001  
Total liabilities and shareholders' equity 50,495,085   50,495,085       50,495,085  
Income Statement                
Gain on change in fair value of warrant liability 0 0 0 0        
Net (loss) income (161,020) (194,207) (470,848) (286,892)        
Basic and diluted earnings (net loss) per share (in dollars per share) $ (0.03) $ (0.03) $ (0.08) $ (0.07)        
Operating activities:                
Net (loss) income (161,020) (194,207) (470,848) (286,892)        
Gain on change in fair value of warrant liability 0 0 0 0        
Scenario, Adjustment [Member]
                
Liabilities:                
Warrant liability 2,152,000   2,152,000       2,152,000  
Total liabilities 2,152,000   2,152,000       2,152,000  
Maximum ordinary shares subject to possible redemption (2,152,000)   (2,152,000)       (2,152,000)  
Equity                
Ordinary shares 216   216       216  
Additional paid-in capital (2,510,883)   (2,510,883)       (2,510,883)  
Retained earnings (Deficit) accumulated during the development stage 2,501,667   2,501,667       2,501,667  
Total shareholders' equity 0   0       0  
Total liabilities and shareholders' equity 0   0       0  
Income Statement                
Gain on change in fair value of warrant liability 2,421,000 179,333 2,331,334 179,333        
Net (loss) income 2,421,000 179,333 2,331,334 179,333        
Basic and diluted earnings (net loss) per share (in dollars per share) $ 0.39 $ 0.03 $ 0.38 $ 0.04        
Operating activities:                
Net (loss) income 2,421,000 179,333 2,331,334 179,333        
Gain on change in fair value of warrant liability (2,421,000) (179,333) (2,331,334) (179,333)        
Scenario, Actual [Member]
                
Liabilities:                
Warrant liability 2,152,000   2,152,000       2,152,000  
Total liabilities 4,506,360   4,506,360       4,506,360  
Maximum ordinary shares subject to possible redemption 40,988,724   40,988,724       40,988,724  
Equity                
Ordinary shares 2,172   2,172       2,172  
Additional paid-in capital 3,292,978   3,292,978       3,292,978  
Retained earnings (Deficit) accumulated during the development stage 1,704,851   1,704,851       1,704,851  
Total shareholders' equity 5,000,001   5,000,001       5,000,001  
Total liabilities and shareholders' equity 50,495,085   50,495,085       50,495,085  
Income Statement                
Gain on change in fair value of warrant liability 2,331,333 179,333 2,331,334 179,333        
Net (loss) income 2,259,980 (14,874) 1,860,486 (107,559)        
Basic and diluted earnings (net loss) per share (in dollars per share) $ 0.36 $ 0.00 $ 0.30 $ (0.03)        
Operating activities:                
Net (loss) income 2,259,980 (14,874) 1,860,486 (107,559)        
Gain on change in fair value of warrant liability $ (2,331,333) $ (179,333) $ (2,331,334) $ (179,333)